117 related articles for article (PubMed ID: 8611427)
1. Characterisation of circulating chromogranin A in human cancer patients.
Corti A; Gasparri A; Chen FX; Pelagi M; Brandazza A; Sidoli A; Siccardi AG
Br J Cancer; 1996 Apr; 73(8):924-32. PubMed ID: 8611427
[TBL] [Abstract][Full Text] [Related]
2. Characterization of serum and urinary chromogranin A by size exclusion chromatography: impact on calibrator selection and urinary assay.
Tsao KC; Liu GH; Chang PY; Lin CN; Wu TL; Sun CF; Wu JT
J Clin Lab Anal; 2001; 15(4):193-8. PubMed ID: 11436202
[TBL] [Abstract][Full Text] [Related]
3. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human chromogranin A: expression, purification and characterization of the N-terminal derived peptides.
Taupenot L; Remacle JE; Helle KB; Aunis D; Bader MF
Regul Pept; 1995 Mar; 56(1):71-88. PubMed ID: 7770635
[TBL] [Abstract][Full Text] [Related]
5. Application of region-specific immunoassay for human chromogranin A: substantial clue for detection and measurement of chromogranin A in human plasma.
Yanaihara H; Hata M; Nishikawa Y; Hoshino M; Yanaihara N; Murai M
Regul Pept; 1999 Mar; 80(1-2):83-90. PubMed ID: 10235638
[TBL] [Abstract][Full Text] [Related]
6. A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245).
Degorce F; Goumon Y; Jacquemart L; Vidaud C; Bellanger L; Pons-Anicet D; Seguin P; Metz-Boutigue MH; Aunis D
Br J Cancer; 1999 Jan; 79(1):65-71. PubMed ID: 10408695
[TBL] [Abstract][Full Text] [Related]
7. Enzyme-linked immunosorbent assay for detection of canine chromogranin A by use of immunological cross-reactivity of rabbit anti-bovine chromogranin A antibody.
Akiyoshi H; Aoki M; Kumagai D; Saleh N; Noda K; Shimada T; Sugii S; Ohashi F
J Vet Med Sci; 2005 May; 67(5):535-7. PubMed ID: 15942141
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin A peptide-specific antisera and high-performance size exclusion chromatography demonstrate amino-terminal and carboxy-terminal fragments of the native molecule in human cell lines.
Brandt DW; Burton DW; Hogue-Angeletti R; Deftos LJ
Proc Soc Exp Biol Med; 1994 Apr; 205(4):316-20. PubMed ID: 8171054
[TBL] [Abstract][Full Text] [Related]
9. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
Baudin E; Gigliotti A; Ducreux M; Ropers J; Comoy E; Sabourin JC; Bidart JM; Cailleux AF; Bonacci R; Ruffié P; Schlumberger M
Br J Cancer; 1998 Oct; 78(8):1102-7. PubMed ID: 9792158
[TBL] [Abstract][Full Text] [Related]
10. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells.
Lee JC; Taylor CV; Gaucher SP; Toneff T; Taupenot L; Yasothornsrikul S; Mahata SK; Sei C; Parmer RJ; Neveu JM; Lane WS; Gibson BW; O'Connor DT; Hook VY
Biochemistry; 2003 Jun; 42(23):6938-46. PubMed ID: 12795588
[TBL] [Abstract][Full Text] [Related]
11. [The sympathetic nervous system activity estimated on serum concentration of chromogranin A in patients with the chronic heart failure].
Rubinsztajn R
Pol Arch Med Wewn; 2001 Mar; 105(3):217-24. PubMed ID: 11680266
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-linked immunosorbent assay for chromogranin A.
Dillen L; De Block J; Van Lear L; De Potter W
Clin Chem; 1989 Sep; 35(9):1934-8. PubMed ID: 2776319
[TBL] [Abstract][Full Text] [Related]
13. Measurement of plasma chromogranin A concentrations for assessment of stress responses in dogs with insulin-induced hypoglycemia.
Akiyoshi H; Aoki M; Shimada T; Noda K; Kumagai D; Saleh N; Sugii S; Ohashi F
Am J Vet Res; 2005 Oct; 66(10):1830-5. PubMed ID: 16273918
[TBL] [Abstract][Full Text] [Related]
14. Regulation of tumor growth by circulating full-length chromogranin A.
Curnis F; Dallatomasina A; Bianco M; Gasparri A; Sacchi A; Colombo B; Fiocchi M; Perani L; Venturini M; Tacchetti C; Sen S; Borges R; Dondossola E; Esposito A; Mahata SK; Corti A
Oncotarget; 2016 Nov; 7(45):72716-72732. PubMed ID: 27683038
[TBL] [Abstract][Full Text] [Related]
15. The post-translational processing of chromogranin A in the pancreatic islet: involvement of the eukaryote subtilisin PC2.
Arden SD; Rutherford NG; Guest PC; Curry WJ; Bailyes EM; Johnston CF; Hutton JC
Biochem J; 1994 Mar; 298 Pt 3(Pt 3):521-8. PubMed ID: 8141763
[TBL] [Abstract][Full Text] [Related]
16. Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker.
Deftos LJ
Endocr Rev; 1991 May; 12(2):181-7. PubMed ID: 2070778
[TBL] [Abstract][Full Text] [Related]
17. A comparison between three commercial kits for chromogranin A measurements.
Stridsberg M; Eriksson B; Oberg K; Janson ET
J Endocrinol; 2003 May; 177(2):337-41. PubMed ID: 12740022
[TBL] [Abstract][Full Text] [Related]
18. Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours.
Nehar D; Lombard-Bohas C; Olivieri S; Claustrat B; Chayvialle JA; Penes MC; Sassolas G; Borson-Chazot F
Clin Endocrinol (Oxf); 2004 May; 60(5):644-52. PubMed ID: 15104570
[TBL] [Abstract][Full Text] [Related]
19. Chromogranin A as a determinant of midgut carcinoid tumour volume.
Kölby L; Bernhardt P; Swärd C; Johanson V; Ahlman H; Forssell-Aronsson E; Stridsberg M; Wängberg B; Nilsson O
Regul Pept; 2004 Aug; 120(1-3):269-73. PubMed ID: 15177946
[TBL] [Abstract][Full Text] [Related]
20. Characterization of natural vasostatin-containing peptides in rat heart.
Glattard E; Angelone T; Strub JM; Corti A; Aunis D; Tota B; Metz-Boutigue MH; Goumon Y
FEBS J; 2006 Jul; 273(14):3311-21. PubMed ID: 16857014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
